Podcast interview with Dexcom CEO Kevin Sayer
Dexcom “Warriors” surround CEO Kevin Sayer on World Diabetes Day 2016
https://healthbb.files.wordpress.com/2016/11/hbdew050-david-e-williams-interviews-dexco-ceo-kevin-sayer.mp3
Kevin Sayer is CEO of Dexcom, and on World Diabetes Day he had the privilege of ringing the NASDAQ bell at the start of the session. I caught up with him afterwards to ask about developments in Continuous Glucose Monitoring.
Here’s what I asked:
(0:10) What is World Diabetes Day and what does it accomplish?
(0:45) Your company is a pioneer in Continuous Glucose Monitoring (CGM). What is the impact on patients?
(1:48) Does CGM replace finger sticks or do you have to do both?
(2:23) Is CGM relevant only for those with insulin pumps? Is it useful for people who inject insulin?
(3:24) What is an artificial pancreas? How does CGM fit in?
(5:15) How do you model the financial impact of CGM for individual patients and for populations?
(6:49) How important are online patient communities and data registries, such as T1D Exchange? Do they play an important role in your R&D?
(8:11) As we look to 2017 and beyond, what are the next big things we can expect?
By healthcare business consultant David E. Williams, president of Health Business Group.
Source: Health Business Blog - Category: Health Management Authors: dewe67 Tags: Devices Podcast continuous glucose monitoring Source Type: blogs